The first Riyadh Health Conference, affiliated with the Ministry of Health in Saudi Arabia, has issued a warning stating that the liquids used in electronic cigarettes may lead to nicotine poisoning.
The conference stated in a tweet on Twitter that "the liquid used in e-cigarettes may cause nicotine poisoning" and explained that "health symptoms caused by nicotine poisoning include vomiting, sweating, dizziness, drowsiness, difficulty breathing, and palpitations.
Recent research warns that electronic cigarettes may trigger cancer cells and potentially lead to a new wave of cancer within a decade.
Saudi Arabia has implemented stricter anti-smoking laws in recent years with the goal of reducing tobacco consumption to approximately 5% of the population by 2030, down from the current limit of 12% based on 2019 statistics.
According to the global anti-smoking website "Da Tobacco Atlas," the number of smokers in Saudi Arabia has decreased by 37% between 2016 and 2020.
2FIRSTS will continue to cover this issue, with further updates available on the '2FIRSTS APP'. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
